Nyxoah completed two major international public offerings to fund its medical device research and commercial expansion: first listing its ordinary shares on Euronext Brussels in September 2020, followed shortly thereafter by a successful U.S. Initial Public Offering on the NASDAQ global market in July 2021 under the ticker symbol NYXH. These public listings broadened the company's institutional shareholder base across North America and Europe.